Beranda › Kolesterol › California
Uji klinis Kolesterol di California
6 studi untuk Kolesterol mencari peserta di lokasi di California.
Teks studi resmi (Bahasa Inggris)
Inclisiran Versus Placebo for the Prevention of Major Adverse Cardiovascular and Limb Events in Patients Undergoing Percutaneous Coronary Intervention or Peripheral Endovascular Intervention
- Pacific Oaks Medical Group, Beverly Hills
- Cardiovascular Institute of San Diego, Chula Vista
- John Muir Medical Center - Concord Campus, Concord
- dan 10 lainnya
Menerima pesertaFase 4
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06909565A Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin and Placebo on LDL-C in LLT-naïve Patients.
- Research Site, Huntington Beach
- Research Site, Loma Linda
- Research Site, Lomita
- dan 2 lainnya
Menerima pesertaFase 3
Usia 18 hingga 130 · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT07619131A Study to Evaluate the Pharmacodynamics of a Combination of QCZ484 and Inclisiran in Participants With Hypertension and Concomitant Hypercholesterolemia
- Clinical Trials Research, Lincoln
- Downtown L A Research Center Inc, Los Angeles
- Valley Clinical Trials, Northridge
Menerima pesertaFase 2
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 30 Jul 2026 · NCT07610278Study to Evaluate Safety, Tolerability and Efficacy of Inclisiran in Children With Homozygous Familial Hypercholesterolemia
- UC San Francisco Medical Center, San Francisco
Menerima pesertaFase 3
Usia 2 hingga 11 · Semua jenis kelamin · Diperbarui 24 Jul 2026 · NCT06597006A Study to See How Safe and Effective Alirocumab is When Given Weekly to Adult Participants Who Have Hypercholesterolemia
- Anaheim Clinical Trials, Anaheim
- Cenexel CNS, Los Alamitos
- Diablo Clinical Research - Flourish Research, Walnut Creek
Menerima pesertaFase 2
Usia 18 hingga 80 · Semua jenis kelamin · Diperbarui 22 Jul 2026 · NCT07477704Study to Evaluate Efficacy and Safety of Inclisiran in Children With Heterozygous Familial Hypercholesterolemia
- UC San Francisco Medical Center, San Francisco
- UC San Francisco Medical Center, San Francisco
Menerima pesertaFase 3
Usia 6 hingga 11 · Semua jenis kelamin · Diperbarui 15 Mei 2026 · NCT06597019Dari ClinicalTrials.gov, data diambil 3 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.